MEIHAO GROUP To Go Ex-Dividend On June 20th, 2024 With 0.01 HKD Dividend Per Share
May 10th - $MEIHAO GROUP(01947.HK)$ is trading ex-dividend on June 20th, 2024. Shareholders of record on June 21st, 2024 will receive 0.01 HKD dividend per share on August 14th, 2024. The ex-divid
Meihao Group (01947) will pay a final dividend of HK$0.01 per share on August 14
According to the Zhitong Finance App, Meihao Group (01947) announced that it will pay a final dividend of HK$0.01 per share for the year ended December 31, 2023 on August 14, 2024.
美皓集團:2023年年報
Meihao Group (01947) will pay a final dividend of HK$0.01 per share
Meihao Group (01947) announced that the company will distribute the end of the year ending December 31, 2023...
Meihao Group (01947) announced its 2023 annual results, with shareholders accounting for a loss of 13.594 million yuan
Meihao Group (01947) announced results for the year ended December 31, 2023, with revenue of 73.513 million...
MEIHAO GROUP: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
Meihao Group (01947): Chen Yuying was appointed as company secretary
Meihao Group (01947) issued an announcement. Li Zhongcheng has resigned as the company's company secretary due to other work arrangements. The company is based on incense...
Meihao Group (01947.HK) plans to hold a board meeting on March 28 to approve the annual results
Glonghui, March 14, 丨 Meihao Group (01947.HK) announced that the company will hold a board meeting on March 28, 2024 (Thursday) to consider and approve the annual results and publication of the company and its subsidiaries for the year ended 31 December 2023, and to consider the proposed payment of a final dividend (if any).
Meihao Medical Warns of Up to 14 Million Yuan Loss in 2023
Meihao Medical Group (HKG:1947) expects a net loss of between 11 million yuan and 14 million yuan for the year ended Dec. 31, 2023, as compared to a net profit of 28.6 million yuan in 2022. The medica
Meihao Group (01947.HK) Profit Alert: Expected annual net loss of about 11 million yuan to 14 million yuan
Gelonghui, Feb. 27丨Meihao Group (01947.HK) announced that according to information currently available to the board of directors and preliminary review of the Group's unaudited comprehensive management accounts for the year ended 31 December 2023, the Group is expected to record a net loss of approximately RMB 11 million to approximately RMB 14 million (year ended 31 December 2022: net profit of RMB 28.6 million). The expected loss is mainly due to the following reasons: (i) The lifting of COVID-19 prevention and control measures and the increase in the number of infections, leading to a decrease in the number of patients seeking medical treatment, combined with the overall decline in the consumer market; (i)
Meihao Group (01947.HK) awarded a total of 24 million bonus shares
Gelonghui, January 16, 丨 Meihao Group (01947.HK) announced that on January 16, 2024, in accordance with the recommendation of the Remuneration Committee, the board of directors decided to grant a total of 24 million award shares free of charge to the four selected Group employees, subject to acceptance by the grantor, and such reward shares will be settled with existing shares purchased from the open market by the trustee using internal resources provided to them by the trustee.
MEIHAO GROUP: Interim Report 2023
Meihao Group (01947.HK)'s medium-term revenue was about 35 million yuan, a year-on-year decrease of about 38.8%
Glonghui, August 28丨Meihao Group (01947.HK) announced that in mid-2023, the company's revenue was approximately RMB 35.0 million, a year-on-year decrease of about 38.8%. The decline in revenue was mainly due to (i) a decrease in the number of medical visits due to an increase in the number of infected people after the novel coronavirus prevention measures were completely lifted, and the overall decline in the Chinese consumer market; (ii) a decrease in revenue from dental implants, which was mainly due to dental implant collection policies. Since some of the costs within the cost of sales category are fixed costs, gross margin fell to around 44.2% (2022:57.2%). Company owners
MEIHAO GROUP: ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2023
Meihao Group (01947.HK) plans to hold a board meeting on August 28 to approve interim results
GLONGHUY, August 16丨Meihao Group (01947HK) announced that the company will hold a board meeting on August 28, 2023 (Monday) to consider and approve the unaudited interim results and publication of the company and its subsidiaries for the six months ended June 30, 2023, and consider the proposed payment of interim dividends (if any).
MEIHAO GROUP: Date of Board Meeting
MEIHAO GROUP: PROFIT WARNING
MEIHAO GROUP: SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE ANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2022
Meihao Group: 2022 Annual Report
Meihao Medical's Profit Slides in 2022 as Expenses Rise
04:41 AM EDT, 03/30/2023 (MT Newswires) -- Meihao Medical Group's (HKG:1947) 2022 attributable profit fell to 28.6 million yuan, or 0.0622 yuan per share, from 32.1 million yuan, or 0.0713 yuan per sh
No Data